Core Insights - ResMed reported quarterly earnings of $2.55 per share, exceeding the Zacks Consensus Estimate of $2.49 per share, and showing an increase from $2.20 per share a year ago, resulting in an earnings surprise of +2.41% [1] - The company achieved revenues of $1.34 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.94% and up from $1.22 billion year-over-year [2] - ResMed has consistently surpassed consensus EPS and revenue estimates over the last four quarters [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $2.65 on revenues of $1.39 billion, and for the current fiscal year, it is $10.75 on revenues of $5.56 billion [7] - The earnings outlook will be influenced by management's commentary during the earnings call, which is crucial for assessing future stock performance [3][4] Industry Context - The Medical - Products industry, to which ResMed belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor sentiment [5] Stock Performance - ResMed shares have increased approximately 10.9% since the beginning of the year, while the S&P 500 has gained 17.2%, indicating underperformance relative to the broader market [3] - The current Zacks Rank for ResMed is 3 (Hold), suggesting that the stock is expected to perform in line with the market in the near future [6]

Core Insights - Indivior PLC reported quarterly earnings of $0.72 per share, exceeding the Zacks Consensus Estimate of $0.38 per share, and showing an increase from $0.54 per share a year ago, resulting in an earnings surprise of +89.47% [1][2] - The company achieved revenues of $314 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 20.81%, and showing a slight increase from $307 million year-over-year [2] - Indivior shares have increased by approximately 103.1% since the beginning of the year, significantly outperforming the S&P 500's gain of 17.2% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.40 on revenues of $255.13 million, and for the current fiscal year, it is $1.72 on revenues of $1.08 billion [7] - The estimate revisions trend for Indivior was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical - Drugs industry, to which Indivior belongs, is currently ranked in the top 37% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

分组1 - Entegris reported quarterly earnings of $0.72 per share, matching the Zacks Consensus Estimate, but down from $0.77 per share a year ago [1] - The company posted revenues of $807.1 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 0.29%, but slightly down from $807.69 million year-over-year [2] - Entegris has surpassed consensus EPS estimates two times and revenue estimates three times over the last four quarters [2] 分组2 - The stock has underperformed, losing about 4.6% since the beginning of the year, compared to the S&P 500's gain of 17.2% [3] - The current consensus EPS estimate for the coming quarter is $0.77 on revenues of $838.2 million, and for the current fiscal year, it is $2.81 on revenues of $3.21 billion [7] - The Electronics - Manufacturing Machinery industry, to which Entegris belongs, is currently ranked in the bottom 23% of over 250 Zacks industries, indicating potential challenges ahead [8]

Core Insights - Cushman & Wakefield (CWK) reported quarterly earnings of $0.29 per share, exceeding the Zacks Consensus Estimate of $0.28 per share, and up from $0.23 per share a year ago, representing an earnings surprise of +3.57% [1] - The company achieved revenues of $2.61 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 4.44%, and an increase from $2.34 billion year-over-year [2] - The stock has gained approximately 26.4% year-to-date, outperforming the S&P 500's gain of 17.2% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.54 on revenues of $2.76 billion, and for the current fiscal year, it is $1.21 on revenues of $10.03 billion [7] - The estimate revisions trend for Cushman & Wakefield was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Real Estate - Operations industry, to which Cushman & Wakefield belongs, is currently ranked in the top 39% of over 250 Zacks industries, suggesting a positive outlook for the sector [8]

Core Insights - PBF Energy reported a quarterly loss of $0.52 per share, better than the Zacks Consensus Estimate of a loss of $0.69, and improved from a loss of $1.5 per share a year ago, resulting in an earnings surprise of +24.64% [1] - The company achieved revenues of $7.65 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.80%, although this was a decline from $8.38 billion in the same quarter last year [2] - PBF Energy's stock has increased by approximately 28.5% year-to-date, outperforming the S&P 500's gain of 17.2% [3] Earnings Outlook - The future performance of PBF Energy's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is -$0.88 on revenues of $7.23 billion, and for the current fiscal year, it is -$5.80 on revenues of $29.29 billion [7] Industry Context - The Oil and Gas - Refining and Marketing industry, to which PBF Energy belongs, is currently ranked in the top 10% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked using tools like the Zacks Rank [5][6]

Core Insights - Biogen Inc. reported quarterly earnings of $4.81 per share, exceeding the Zacks Consensus Estimate of $3.89 per share, and showing an increase from $4.08 per share a year ago, resulting in an earnings surprise of +23.65% [1] - The company generated revenues of $2.53 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 8.31% and reflecting a year-over-year increase from $2.47 billion [2] - Biogen has outperformed consensus EPS estimates three times over the last four quarters and has topped consensus revenue estimates four times during the same period [2] Earnings Outlook - The sustainability of Biogen's stock price movement will largely depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $3.38 on revenues of $2.27 billion, while for the current fiscal year, the estimate is $15.74 on revenues of $9.68 billion [7] Industry Context - The Medical - Biomedical and Genetics industry, to which Biogen belongs, is currently ranked in the top 38% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

分组1 - Xcel Energy reported quarterly earnings of $1.24 per share, missing the Zacks Consensus Estimate of $1.31 per share, and showing a slight decrease from $1.25 per share a year ago, resulting in an earnings surprise of -5.34% [1] - The company posted revenues of $3.92 billion for the quarter ended September 2025, which was 0.33% below the Zacks Consensus Estimate, and an increase from $3.64 billion year-over-year [2] - Over the last four quarters, Xcel has surpassed consensus EPS estimates only once and has not beaten consensus revenue estimates during the same period [2] 分组2 - The stock has gained approximately 18% since the beginning of the year, outperforming the S&P 500's gain of 17.2% [3] - The current consensus EPS estimate for the upcoming quarter is $0.89 on revenues of $3.69 billion, and for the current fiscal year, it is $3.81 on revenues of $14.81 billion [7] - The Zacks Industry Rank for Utility - Electric Power is in the top 24% of over 250 Zacks industries, indicating a favorable outlook for the industry [8]

Core Insights - Markel Group reported quarterly earnings of $30.9 per share, exceeding the Zacks Consensus Estimate of $22.77 per share, and showing a significant increase from $17.34 per share a year ago, resulting in an earnings surprise of +35.70% [1][2] - The company achieved revenues of $3.93 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.66% and up from $3.69 billion year-over-year [2] - Markel Group has consistently outperformed consensus EPS estimates over the last four quarters, achieving this four times [2] Earnings Outlook - The future performance of Markel Group's stock will largely depend on management's commentary during the earnings call and the sustainability of the stock's immediate price movement based on the recently released numbers [3][4] - The current consensus EPS estimate for the upcoming quarter is $22.73, with expected revenues of $3.75 billion, and for the current fiscal year, the estimate is $95.64 on revenues of $15.04 billion [7] Industry Context - The Zacks Industry Rank indicates that the Diversified Operations sector is currently in the top 30% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors or through tools like the Zacks Rank [5][6]

Core Viewpoint - Cactus, Inc. reported quarterly earnings of $0.67 per share, exceeding the Zacks Consensus Estimate of $0.58 per share, but down from $0.79 per share a year ago, indicating a +15.52% earnings surprise [1] Financial Performance - The company achieved revenues of $263.95 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 3.86%, but down from $293.18 million year-over-year [2] - Over the last four quarters, Cactus has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] Stock Performance - Cactus shares have declined approximately 32.5% since the beginning of the year, contrasting with the S&P 500's gain of 17.2% [3] Future Outlook - The company's earnings outlook will be crucial for investors, particularly in light of recent earnings expectations and revisions [4] - The current consensus EPS estimate for the upcoming quarter is $0.56 on revenues of $248.55 million, and for the current fiscal year, it is $2.46 on revenues of $1.06 billion [7] Industry Context - The Oil and Gas - Integrated - United States industry, to which Cactus belongs, is currently ranked in the bottom 18% of over 250 Zacks industries, indicating potential challenges ahead [8]

Core Insights - Axis Capital reported quarterly earnings of $3.25 per share, exceeding the Zacks Consensus Estimate of $2.72 per share, and showing an increase from $2.71 per share a year ago, resulting in an earnings surprise of +19.49% [1] - The company achieved revenues of $1.64 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.71% and up from $1.58 billion year-over-year [2] Earnings Performance - Over the last four quarters, Axis Capital has consistently surpassed consensus EPS estimates, achieving this four times [2] - The company had a previous quarter earnings expectation of $2.88 per share but reported $3.29, resulting in a surprise of +14.24% [1] Stock Performance and Outlook - Axis Capital shares have increased by approximately 0.5% since the beginning of the year, while the S&P 500 has gained 17.2% [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the earnings outlook [4][6] Earnings Estimates - The current consensus EPS estimate for the upcoming quarter is $2.95 on revenues of $1.64 billion, and for the current fiscal year, it is $12.15 on revenues of $6.41 billion [7] Industry Context - The Insurance - Property and Casualty industry, to which Axis Capital belongs, is currently ranked in the top 14% of over 250 Zacks industries, indicating a favorable outlook for stocks in this sector [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked using tools like the Zacks Rank [5]